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Introduction {#sec1}
============

Macrophages are versatile and plastic cells that have the ability to fuse and give rise to multinucleate cells ([@bib15]). Macrophage fusion leads to the formation of osteoclasts in bone and multinucleate giant cells (MGCs) in chronic inflammatory diseases ([@bib11; @bib22; @bib62]). Thus, both osteoclasts and MGCs are derived from the fusion of macrophages. Multinucleation represents an essential step in osteoclast formation and activation because mononucleate osteoclasts are unable to resorb bone efficiently ([@bib22; @bib62; @bib63]) and the genes that are critical for osteoclast activity are also fundamental to MGC function ([@bib12; @bib19; @bib66; @bib67]). Despite the well-characterized role of osteoclasts in bone homeostasis, macrophage activation associated with MGC formation in inflammatory diseases remains poorly understood.

Genetic studies in mice and humans suggest that germline sequence variation can regulate macrophage multinucleation and that this can influence disease pathogenesis. In a murine model of chronic tuberculosis infection, genetic loci were associated with production of inflammatory mediators by macrophages ([@bib33; @bib49]), suggesting the presence of a heritable genetic component affecting MGC function, which, in turn, mediates susceptibility to granulomatous diseases. In humans, deletions or loss-of-function mutations in either the *TYROBP* (DAP12) or *TREM2* genes are causally associated with Nasu-Hakola disease ([@bib46; @bib47]), where defective multinucleation in osteoclasts results in impaired bone resorption ([@bib27]). In addition, human genome-wide association studies of MGC-associated diseases such as tuberculosis ([@bib57]) and granulomatosis with polyangiitis ([@bib41]) identified common sequence variations associated with these disorders. In rheumatoid arthritis (RA), osteoclast differentiation and activation lead to bone erosion associated with prolonged inflammation ([@bib43]). However, to date, genetic studies failed to identify genes and pathways involved in osteoclast activation resulting from multinucleation. Hence, the key determinants and molecular pathways of multinucleation in macrophages and the resulting pathophysiological effects remain largely unexplored.

Results {#sec2}
=======

Identification of a Multinucleation Gene Network in Macrophages {#sec2.1}
---------------------------------------------------------------

In order to investigate the genetic components of MGC formation, we took advantage of strain-specific phenotypic differences in spontaneous formation of MGCs in the rat, which have not been described previously. We observed that when bone-marrow-derived macrophages (BMDMs) from Wistar Kyoto (WKY) rats and Lewis (LEW) rats are cultured in vitro, WKY macrophages spontaneously form MGCs in contrast with what is observed in LEW ([Figures 1](#fig1){ref-type="fig"}A and [S1](#app3){ref-type="sec"}). These strains have been widely studied for their differential susceptibility to experimental glomerulonephritis through macrophage activation ([@bib1; @bib5; @bib6; @bib45]), and WKY rats also show MGCs in their glomeruli following the induction of nephrotoxic nephritis (NTN) ([Figure S1](#app3){ref-type="sec"}). These marked phenotypic differences suggested genetic determinants of the process underlying MGC formation in the rat, which we set out to investigate by profiling genome-wide expression levels in macrophages of 200 backcross rats derived from WKY and LEW.

We used mRNA expression level as a quantitative trait to carry out genome-wide linkage analysis using a panel of single nucleotide polymorphisms (SNPs) throughout the rat genome. Using multivariate Bayesian regression approaches ([@bib8]), we identified a set of 2,357 transcripts showing significant linkages to discrete genetic loci (posterior probability \>80%), which are designated as expression quantitative trait loci (eQTLs, [Figure S2](#app3){ref-type="sec"}). The majority of transcripts were regulated by local genetic variation forming *cis-*eQTLs (67%); however, we also identified many *trans*-regulated transcripts (*trans*-eQTLs) across the rat genome ([Figure 1](#fig1){ref-type="fig"}B). As previously reported ([@bib25; @bib36]), *trans*-eQTLs can form clusters that are commonly referred to as *trans*-eQTLs hot spots ([@bib10]) ([Table 1](#tbl1){ref-type="table"}). Notably, we identified a large eQTL hot spot that mapped to three SNPs spanning a genomic region of 1.2 Mbp located on rat chromosome 9q11, which regulated in *trans* the expression of 190 transcripts ([Table 1](#tbl1){ref-type="table"}; [Figure 1](#fig1){ref-type="fig"}B). These 190 transcripts formed a gene coexpression network, where each gene is regulated in *trans* by the same genetic locus ([Figure 1](#fig1){ref-type="fig"}C). Cell-type enrichment analysis using a mouse gene expression atlas showed that the gene network is enriched for osteoclast genes (enrichment p value = 4 × 10^−7^, *Z* test for relative overexpression of the network genes in a tissue/cell type, see [Supplemental Experimental Procedures](#app3){ref-type="sec"}), suggesting a role for the network in macrophage multinucleation ([Figure 1](#fig1){ref-type="fig"}C). Closer inspection of the network genes revealed two major determinants of osteoclast activity (*Mmp9* and cathepsin K, reviewed in [@bib22]) as well as several reported regulators of macrophage multinucleation such as *P2rx7* ([@bib38]), *Tm7sf4* (also known as DC-STAMP \[[@bib66]\]), osteopontin (*Osp*) ([@bib59]), *Pik3cb* (also known as PI3K \[[@bib48]\]), tetraspanin *Cd9* ([@bib54]), and its binding partner *Igsf8*. We hypothesize that other genes of the large coexpression network might regulate macrophage multinucleation, therefore defining a "Macrophage Multinucleation Network" or MMnet.

To prioritize master regulator genes at the rat chromosome 9 locus, we carried out fine mapping analysis and, among others, identified the Triggering receptor expressed in myeloid cells (*Trem*) gene family cluster within the 2-LOD drop support interval of the peak of linkage ([Figure 1](#fig1){ref-type="fig"}D). At this locus, the *Trem* family genes showed the strongest *cis*-acting genetic regulation in macrophages (variation in gene expression explained by the regulatory locus; *R*^2^ \> 0.25, [Figures 1](#fig1){ref-type="fig"}E), and, among all genes in the MMnet, *Kcnn4* was the most significant *trans*-eQTL ([Figure 1](#fig1){ref-type="fig"}E). Quantitative real-time PCR analysis of the expression of the *Trem* family genes in backcross macrophages confirmed their *cis*-regulation and prioritized *Trem2* as the most highly expressed gene in rat macrophages (\>90-fold more expression compared to all other genes in the *Trem* cluster, [Figure 1](#fig1){ref-type="fig"}F).

Identification of *Trem2* as a Master Genetic Regulator of the MMnet {#sec2.2}
--------------------------------------------------------------------

We observed a positive correlation between the expression of *Trem2* and 125 (66%) MMnet genes and a negative correlation between *Treml1*, *D3ZDX3_Rat*, *Treml2*, and the network genes ([Figure 2](#fig2){ref-type="fig"}A). We selected ten genes from the MMnet, including the most strongly *trans*-regulated gene (*Kcnn4, R*^2^ = 0.25), genes previously reported to play a role in macrophage multinucleation (*P2rx7* \[[@bib38]\], *Tm7sf4* \[[@bib66]\], *Pik3cb* \[[@bib48]\], tetraspanin *Cd9* \[[@bib54]\]) and additional *trans*-regulated MMnet genes with varying genetic effects (*R*^2^ ranging from ∼0.1 to 0.22). These genes recapitulate the correlation pattern observed between the *Trem* cluster genes and the MMnet ([Figure 2](#fig2){ref-type="fig"}B). We carried out RNAi experiments to further prioritize candidates within the *Trem* gene cluster as potential master regulators of the MMnet, by using small interfering RNA (siRNA) against *Treml1*, *Trem2*, *D3ZDX3_Rat*, and *Treml2* genes that were differentially expressed between WKY and LEW macrophages ([Figure 1](#fig1){ref-type="fig"}F), followed by quantitative real-time PCR assessment of ten *trans*-regulated genes from the network. In keeping with the positive correlation between *Trem2* and the MMnet genes ([Figures 2](#fig2){ref-type="fig"}A and 2B), we found significant downregulation of the *trans*-regulated genes after *Trem2* silencing ([Figure 2](#fig2){ref-type="fig"}C). On the contrary, silencing of *Treml1*, *D3ZDX3_Rat*, and *Treml2* resulted in a weaker and variable downregulation of the network genes ([Figure 2](#fig2){ref-type="fig"}C). This downregulation was not in accordance with the expected transcriptional response based on the negative correlation between *Treml1*, *D3ZDX3_Rat*, *Treml2*, and each *trans*-eQTL gene expression ([Figure 2](#fig2){ref-type="fig"}B). These in vitro experiments prioritized *Trem2* as a master regulator gene of the MMnet in the rat. We then explored whether silencing of *TREM2* in monocyte-derived macrophages had a similar effect on the *trans*-eQTL network genes in humans ([Figure 2](#fig2){ref-type="fig"}D). We showed that there was a significant correlation between the percentage of knockdown in human MDMs and rat BMDMs following *Trem2* knockdown ([Figure 2](#fig2){ref-type="fig"}E). These data suggest that the *Trem2-*regulated MMnet genes identified in rat macrophages are similarly regulated in human macrophages.

Taken together, genome-wide eQTL analysis and in vitro experiments uncovered a large gene network regulating macrophage multinucleation, which is under *trans*-acting genetic control by the *Trem2* gene in rats and humans.

*Kcnn4* Is Implicated in Macrophage Multinucleation in Rodents and Humans {#sec2.3}
-------------------------------------------------------------------------

Because multinucleate osteoclasts and MGCs originate from macrophages ([@bib62]), our data suggest that MMnet controlled by *Trem2* may contain novel genes regulating macrophage multinucleation. We therefore hypothesized that the most significant *trans*-eQTL in the network (*R*^2^ = 0.25, p = 3.8 × 10^−16^, [Figure 1](#fig1){ref-type="fig"}E), *Kcnn4,* encoding an intermediate-conductance calcium-activated potassium channel, regulates multinucleation in macrophages. *Kcnn4* expression peaked during macrophage multinucleation ([Figure S3](#app3){ref-type="sec"}) and a separate time-dependent microarray analysis of fusing rat alveolar macrophages and human monocytes revealed *Kcnn4* as a differentially expressed gene, which is strongly induced at the onset of fusion ([Figure S3](#app3){ref-type="sec"}). We therefore investigated whether *Kcnn4* determines multinucleation in osteoclasts and MGCs, two cell types resulting from multinucleation in physiological and pathological conditions, respectively. To this aim, we used two selective distinct pharmacological blockers (ICA-17043 and TRAM-34) of Kcnn4 in human and rodent osteoclasts and MGCs and confirmed the effect of these blockers with targeted gene deletion and RNAi for *Kcnn4* ([Figure 3](#fig3){ref-type="fig"}). Transfection with siRNA designed against *Kcnn4* ([Figure 3](#fig3){ref-type="fig"}A), selective pharmacological blockade ([Figures 3](#fig3){ref-type="fig"}B and 3D), and targeted gene deletion ([Figure 3](#fig3){ref-type="fig"}C) of *Kcnn4* consistently decreased macrophage multinucleation in rodents. Similar results were obtained in human osteoclasts and MGCs ([Figures 3](#fig3){ref-type="fig"}E and 3F), indicating that *Kcnn4* regulates macrophage multinucleation in rodents and humans. The inhibitory effect of TRAM-34 on macrophage multinucleation is reversible and TRAM-34 does not affect macrophage differentiation ([Figure S3](#app3){ref-type="sec"}) but changes the macrophage transcriptome assessed by high-throughput sequencing of mRNA (RNA-seq, [Figure S3](#app3){ref-type="sec"}). Furthermore, in order to assess whether the absence of *Kcnn4* affects preosteoclast formation, we have quantified TRAP^+^ mononuclear cells isolated from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice at day 3, 4, and 5 of cell differentiation and showed that early steps of osteoclast differentiation do not seem to be affected by *Kcnn4* deficiency ([Figure S3](#app3){ref-type="sec"}).

*Kcnn4* Modulates Bone Turnover {#sec2.4}
-------------------------------

Given our data implicating *Kcnn4* in macrophage multinucleation and because defects in osteoclast formation impact bone resorption ([@bib56]), we tested whether *Kcnn4* deficiency affects bone mass. Femurs from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ female and male mice were analyzed by X-ray, peripheral quantitative computed tomography (pQCT), and microcomputed tomography (microCT). These analyses consistently revealed increased bone mass and density in both female and male *Kcnn4*^−/−^ mice compared with *Kcnn4*^+/+^ mice ([Figure 4](#fig4){ref-type="fig"}). In particular, femurs from *Kcnn4*^−/−^ mice showed increased (1) X-ray absorption ([Figure 4](#fig4){ref-type="fig"}A), (2) total bone mineral density (9% and 14% increases in females and males, respectively), (3) trabecular bone density (30% and 29% in females and males), and (4) trabecular bone volume fraction (27% and 26% in females and males) ([Figures 4](#fig4){ref-type="fig"}B and 4C). Accordingly, *Kcnn4*^−/−^ mice had reduced numbers of TRAP-positive osteoclasts ([Figure S4](#app3){ref-type="sec"}) and a reduced number of osteoclasts per unit of bone surface ([Figures 4](#fig4){ref-type="fig"}D and [S4](#app3){ref-type="sec"}; [Table S1](#app3){ref-type="sec"}), thus supporting a role for *Kcnn4* in osteoclast formation in vivo. Furthermore, *Kcnn4*^−/−^ mice also displayed increased bone formation and mineral apposition rates compared with *Kcnn4*^+/+^ mice, indicating the high bone mass phenotype in *Kcnn4*^−/−^ mice results from effects on both bone formation and bone resorption ([Table S1](#app3){ref-type="sec"}). We next investigated whether osteoclast activity was decreased in *Kcnn4*^−/−^ mice in an inflammation-induced calvaria bone resorption provocation model. This study revealed that *Kcnn4*^−/−^ mice lacked the normal osteoclast-mediated bone resorption response to inflammation ([Figure 4](#fig4){ref-type="fig"}E). We also showed that deletion of *Kcnn4* results in reduced osteoclastic resorption in vitro ([Figure S4](#app3){ref-type="sec"}). Taken together, these data indicate that *Kcnn4* participates in the control of bone turnover by regulating functional osteoclast formation and suggest that its effects on bone formation may be mediated via a primary role in osteoclasts.

Inactivation of *Kcnn4* Reduces Severity of Glomerulonephritis and Bone Erosion in Arthritis {#sec2.5}
--------------------------------------------------------------------------------------------

To study the role of *Kcnn4* in macrophage multinucleation in pathological conditions, we used two inflammatory models in rodents, characterized by MGC and osteoclast activation: glomerulonephritis and arthritis, respectively. In crescentic glomerulonephritis (Crgn), we blocked *Kcnn4* with its selective inhibitor TRAM-34 ([@bib64]) in the WKY NTN model characterized by glomerular MGCs ([Figure S1](#app3){ref-type="sec"}; [@bib35]). In the WKY NTN model, the severe and reproducible glomerular macrophage infiltration following nephrotoxic serum injection ([@bib55]) is also characterized by approximately 20% of glomeruli presenting MGCs ([Figures 5](#fig5){ref-type="fig"} and [S1](#app3){ref-type="sec"}). It is therefore possible to study the effect of TRAM-34 on glomerular MGC formation and renal injury assessed by proteinuria. TRAM-34 treatment of WKY rats with NTN led to significant reduction of glomerular crescents, glomerular MGC formation, and proteinuria without affecting the number of macrophages infiltrating the glomeruli ([Figures 5](#fig5){ref-type="fig"}A and 5B). To evaluate the role of Kcnn4 in bone erosion in inflammatory arthritis, we assessed the effect of *Kcnn4* deficiency in anticollagen antibody-induced arthritis (CAIA) and showed that *Kcnn4*^−/−^ mice have reduced joint inflammation and tissue damage ([Figures 5](#fig5){ref-type="fig"}C, 5D, and [S5](#app3){ref-type="sec"}). Following CAIA serum bone resorption (CTX) and bone formation (P1NP) markers were measured in *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice. *Kcnn4* deficiency resulted in impaired osteoclastic bone resorption that was not affected by CAIA but did not affect osteoblastic bone formation ([Figure S5](#app3){ref-type="sec"}). This is consistent with the results obtained in the lipopolysaccharide (LPS)-induced calvaria model ([Figure 4](#fig4){ref-type="fig"}E) showing reduced osteoclast activity in vivo. Taken together, the results obtained from the LPS and CAIA experiments suggest that reduced bone loss in *Kcnn4*^−/−^ mice can be attributed to decreased osteoclast activity resulting from impaired multinucleation.

*Kcnn4* Regulates Ca^2+^ Signaling in Macrophage Multinucleation {#sec2.6}
----------------------------------------------------------------

In order to investigate the mechanism by which *Kcnn4* regulates multinucleation, we focused on intracellular Ca^2+^ levels because of the established link between K^+^ channels and Ca^2+^ influx during lymphocyte activation ([@bib21]). We assessed whether pharmacological blockade or gene deletion of *Kcnn4* results in disturbed Ca^2+^ signaling and oscillations and revealed that there are decreased Ca^2+^ oscillations in *Kcnn4*^−/−^ osteoclasts compared to *Kcnn4*^+/+^ ([Figure 6](#fig6){ref-type="fig"}A). We also detected differences between *Kcnn4*^+/+^ and *Kcnn4*^−/−^ macrophages in patch clamp experiments, including a shift in observed reversal potential following gene deletion or inhibition of Kcnn4 ([Figure 6](#fig6){ref-type="fig"}B). One of the major downstream effects of receptor activator of nuclear factor kappa-B ligand (RANKL)-induced activation of Ca^2+^ signaling is nuclear translocation of dephosphorylated nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) ([@bib53]), and, consistent with this, there was reduced expression of NFATc1 in *Kcnn4*^−/−^ osteoclasts ([Figure 6](#fig6){ref-type="fig"}C). The reduced NFATc1 expression was associated with decreased nuclear translocation in *Kcnn4*^−/−^ bone-marrow-derived macrophages in response to RANKL ([Figure 6](#fig6){ref-type="fig"}D). Similarly, WKY BMDMs treated with TRAM-34 exhibit reduced *Nfatc1* expression associated with decreased multinucleation (data not shown). To elucidate the mechanisms by which *Kcnn4* affects osteoclast differentiation, we stimulated macrophages with RANKL or LPS for increasing time periods and found that RANKL-induced p38 and ERK activation were not modified by *Kcnn4* deficiency (data not shown). In contrast, RANKL-induced Akt activation was reduced ([Figure S6](#app3){ref-type="sec"}). This result was confirmed in human macrophages treated with TRAM-34 ([Figure S6](#app3){ref-type="sec"}). Because Akt has been shown to be a critical mediator of cell proliferation and survival in a variety of cell types ([@bib51]), our results showing impaired Akt phosphorylation in association with *Kcnn4* deficiency suggested that Kcnn4 may regulate apoptosis. Supporting this hypothesis, deletion of *Kcnn4* was associated with increased apoptosis in osteoclasts ([Figure S6](#app3){ref-type="sec"}).

Discussion {#sec3}
==========

Using systems genetics approaches, our study demonstrates how genomic sequence variation affects a unique regulatory network that is associated with macrophage multinucleation in the rat. By conducting an eQTL study in the primary macrophages of a backcross rat population derived from two inbred rat strains with contrasting phenotypes ("markedly fusogenic WKY macrophages" versus "lowly fusogenic LEW macrophages"), we have identified a unique gene regulatory network (MMnet) associated with macrophage multinucleation in the rat. We show that *Trem2* regulate MMnet, which was enriched for genes regulating osteoclast formation in the rat, a result that was confirmed in human macrophages. Consistent with the previously established role of *Trem2* in macrophage fusion ([@bib23]), activation ([@bib60]), and osteoclast formation ([@bib14; @bib28; @bib44]), here, we demonstrate that the strongest *trans*-eQTL in the *Trem2*-controlled gene network, *Kcnn4*, is a key determinant of macrophage multinucleation in rodent and human osteoclasts and MGCs. We independently confirmed the role of *Kcnn4* as a potential modulator of multinucleation by microarray analysis of fusing rat macrophages and human monocytes that form osteoclasts. We show that *Kcnn4* inhibitors prevent the formation of monocyte-derived human osteoclasts and MGCs, in addition to mouse bone-marrow-derived osteoclasts and rat MGCs.

The intermediate-conductance Ca^2+^-activated K^+^ channel Kcnn4 (also known as Kca3.1 or IK1) is activated in response to increases in intracellular Ca^2+^ through calmodulin bound to its intracellular C terminus ([@bib34]). The blockade of this channel by a selective small molecule inhibitor (TRAM-34) was first shown to have immunosuppressive effects on T lymphocytes ([@bib64]) and further tested on T cell-mediated diseases such as inflammatory bowel disease, experimental autoimmune encephalomyelitis, rheumatoid arthritis, and asthma (reviewed in [@bib34]). Although *Kcnn4* is expressed in macrophages, its role in macrophage multinucleation has not previously been reported. Treatment with TRAM-34 improved atherosclerosis in *ApoE*^−/−^ mice aortas and carotid arteries by decreasing macrophage infiltration and by possibly inhibiting their migration ([@bib58]). Similarly, TRAM-34 treatment reduced ED1^+^ macrophages and microglia in the rat brain following ischemia/reperfusion stroke ([@bib17]), and, more recently, it has been shown that blockade of Kcnn4 reduced F4/80^+^ cells in a streptozotocin-induced diabetic mouse model ([@bib24]).

Although it had been reported that Ca^2+^-activated K^+^ currents are involved in the regulation of osteoclast movement and spreading on bone substrates, and that increase in intracellular Ca^2+^ blocks osteoclast bone resorption in vitro ([@bib61]), the specific contribution of *Kcnn4* in inflammation-induced osteoclast development in vivo was not previously reported. The effect of Kcnn4 on bone mass is modest compared to its critical regulatory role in osteoclast and macrophage multinucleation. This is consistent with previous findings demonstrating a relatively mild effect of macrophage fusion marker (DC-STAMP) on bone mass ([@bib66]). At this stage, the bone formation abnormality observed in *Kcnn4*^−/−^ mice remains incompletely understood and additional studies to investigate further will require detailed analysis of *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice at various ages during development and adulthood, as well as cell-specific gene targeting approaches because it was previously used for studying the effect of cathepsin-k deletion on bone formation ([@bib40]).

We also show that *Kcnn4* affects macrophage multinucleation without having an effect on preosteoclast formation, a result previously documented for *Atp6v0d2*, a regulator of osteoclast fusion ([@bib37]). Here, we show that *Kcnn4*-deficient mice fail to mount an osteoclastic response to local injection of LPS into calvaria. Local osteoclast formation and bone loss are a major component of the pathogenesis of metabolic and inflammatory bone diseases ([@bib9]). Thus, *Kcnn4*, which was previously reported as a potential target for immunosuppression ([@bib13; @bib30]), autoimmune diseases ([@bib65]), and periodontal disease ([@bib61]), also represents a potential new target for the prevention of inflammation-related bone loss.

The WKY NTN model of Crgn is characterized by glomerular MGC formation ([@bib32]) and the renal injury is entirely dependent on macrophage infiltration and activation ([@bib1; @bib5; @bib6; @bib18; @bib20; @bib26; @bib45]). We show that blocking *Kcnn4* in vivo by administration of TRAM-34 significantly reduces glomerular injury in the WKY NTN model. Although we did not observe different numbers of glomerular macrophages between TRAM-34 and vehicle-treated animals, there was a reduction in glomerular MGCs, which suggests that *Kcnn4* blockade reduced multinucleation in vivo by preventing disease. In keeping with this, we show that *Kcnn4* deletion leads to a reduced severity in chronic inflammatory arthritis characterized by osteoclast activation. Collagen-induced arthritis is characterized by focal collections of osteoclasts at sites of bone destruction, and previous reports showed that osteoclast depletion ameliorated bone erosion in this model ([@bib50; @bib52]). Our results showing reduced bone loss in anticollagen antibody-induced arthritis in *Kcnn4*^−/−^ mice support these findings. However, the effect of *Kcnn4* deletion in the CAIA model could be driven by either inflammation or osteoclast-mediated bone erosion/resorption. Further studies using osteoclast-specific *Kcnn4* knockout mice will be crucial in dissecting the relative contribution of inflammation and osteoclast-driven responses in this model.

The measurements of intracellular Ca^2+^ reveal that *Kcnn4* deficiency reduces the amplitude of Ca^2+^ oscillations, but not their frequency, suggesting that K^+^ currents through the Kcnn4 channel contribute to the sustained Ca^2+^ oscillations mainly via the regulation of membrane potential, rather than Ca^2+^ mobilization from intracellular Ca^2+^ stores. Absence of *Kcnn4* appears to affect several downstream signaling pathways, including NFATc1 via calcium signaling, and Akt activation, which together lead to decrease survival of multinucleate macrophages.

In summary, using a systems genetics approach, we identified a *trans*-regulated multinucleation network in macrophages and provided compelling evidence that at least one gene within the network (*Kcnn4*) regulates macrophage multinucleation in bone homeostasis. We also show that Kcnn4 can be effectively targeted to decrease severity of inflammatory conditions characterized by MGC or osteoclast activation.

Experimental Procedures {#sec4}
=======================

Animals, Genetic Crosses, and Genotyping {#sec4.1}
----------------------------------------

Wistar-Kyoto (WKY/NCrl) rats and Lewis (LEW/Crl) were purchased from Charles River UK. Two hundred Backcross (BC) rats were produced by breeding WKY with LEW rats (congenic WKY rats were used where the previously identified crescentic glomerulonephritis QTLs on chromosome 13 and 16 were introgressed from the LEW rats \[[@bib6]\]). The (WKY x LEW) F1 animals were backcrossed to the congenic WKY rats. For genotyping, DNA was isolated from the BC rat spleens using a standard phenol-chloroform extraction. DNA (250 ng) was used for NspI and StyI fragmentation according to Affymetrix SNP6.0 GeneChip instructions. Custom designed Whole Genome Rat Genotyping arrays (RATDIV arrays, MDC) that contain 803,484 SNPs covering the rat genome (based on Rn3.4 version) were used. SNP calling was performed using the BRLMM algorithm and led to the identification of 785,247 SNPs with \>95% call rate (see [Supplemental Experimental Procedures](#app3){ref-type="sec"} for additional details). *Kcnn4*^−/−^ mice were generated on a mixed 129J/C57BL6 background, bred, and genotyped as previously described ([@bib4]). The animals were housed in standard caging on a 12-hr-light cycle and were offered free access to rodent chow (Harlan Teklad \#2018 Rodent Diet) and water.

Bone X-Ray Radiography, pQCT, microCT, and Histomorphometry in Mice {#sec4.2}
-------------------------------------------------------------------

Excised femurs were subjected to X-ray using a MX-20 (Faxitron X-ray) at 30 kV for 3 s. X-ray films were scanned using an Epson Perfection 4870. Bone density was determined as described previously ([@bib2]) by Peripheral Quantitative Computed Tomography (pQCT, XCT Research M; Norland Medical Systems) of a virtual 1 mm cross-section of the distal femur 0.25 mm proximal to the growth plate. In addition, distal femurs were scanned with a Microcomputed Tomography (microCT) scanner (MicroCT 40; Scanco) with a 2,048 × 2,048 matrix and isotropic resolution of 12 μm^3^ voxel size. 3D trabecular measurements in the secondary spongiosa were made directly, as previously described ([@bib39]). Femurs and tibiae from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice were dehydrated in a graded ethanol series and embedded without decalcification in methylmethacrylate, as we described previously ([@bib3]). Four-micrometer-thick cross-sections of the distal femur were stained with Villanueva Mineralized Bone Stain for static histomorphometric analysis (see [Supplemental Experimental Procedures](#app3){ref-type="sec"}), whereas 8-μm-thick sections were left unstained for dynamic bone histomorphometric parameters.

All procedures were approved by the Yale University Institutional Animal Care and Use Committee. The care and treatment of experimental mice complied with all applicable federal guidelines and was approved by the Institutional Animal Care and Use Committee at Yale University.

Microarray Expression Profiling, eQTL Mapping, and Network Analysis {#sec4.3}
-------------------------------------------------------------------

Total RNA was extracted from BMDMs from 200 backcross rats using TRIzol (Invitrogen), and gene expression was measured using Affymetrix 1.0 ST Rat Gene array. WKY-LEW next-generation sequencing data (Illumina Hiseq 2000) was used to remove SNP-containing probes prior to normalization. Arrays were normalized using RMA normalization from the Affymetrix package ([@bib29]). Normalization step included Norm-exp background correction and quantile normalization. Probes signal were summarized at a transcript level using median polish. The resulting data were log transformed ([Figure S2](#app3){ref-type="sec"}). Remaining batch effects were removed using ComBat ([@bib16; @bib31]) with nonparametric prior. All other parameters were left to default. The first two principal components of the normalized data before and after correcting for batch effects are shown in [Figure S2](#app3){ref-type="sec"}. The eQTL mapping was performed using ESS++ ([@bib7; @bib8]). Fixed effects on each individual were added as covariates in the variable selection process to account for potential outliers or genotyping errors. eQTL analysis details, network inference, and cell-type enrichment analysis are described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Nephrotoxic Nephritis in Rats and Collagen Antibody-Induced Arthritis in Mice {#sec4.4}
-----------------------------------------------------------------------------

The effect of TRAM-34 on nephrotoxic nephritis (NTN) in the WKY rat was assessed as follows: eight male WKY rats were injected with the nephrotoxic serum (NTS) as previously described ([@bib18]). A group of four rats received intraperitoneal injections of TRAM-34 (40 mg/kg) in Miglyol 812 neutral oil (Kemcare) at 1 μl/g, twice a day with 10 hr intervals for 7 days. The control group (n = 4) had IP injections of Miglyol (vehicle). Rats were killed 7 days following injection of NTS, and glomerular crescents and proteinuria were measured as previously described ([@bib18]). Chronic inflammatory arthritis was induced in 8-week-old male and female *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice by intraperitoneal (i.p.) injection of 7 mg (700 μl) of Arthrogen monoclonal antibodies (ArthoMAB) blend (Millipore) on day 0. This cocktail of monoclonal antibodies is directed against epitopes recognized in the region CB11 of collagen type II. On day 3, 50 μg (\<100 μl volume) of LPS was administered i.p. Beginning on day 4, the animals were monitored daily for the onset and development of collagen-antibody-induced arthritis (CAIA), and the injection site on each animal was evaluated for signs of infection, such as heat, redness, and/or exudation. Mice that felt as "cold," which likely underwent cachexia in response to LPS, received subcutaneous injection of 500 μl of warm Ringer solution. Arthritic severity was monitored daily using a visual scoring system ([Supplemental Experimental Procedures](#app3){ref-type="sec"}). The histopathological evaluation of CAIA is described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.
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![Identification of *Kcnn4* within a Genetically Regulated Macrophage Multinucleation Network\
(A) Genetic determinants of macrophage multinucleation were explored in WKY and LEW bone-marrow-derived macrophages (BMDMs). WKY macrophages fuse spontaneously to form multinucleate giant cells (MGCs) in vitro and show a marked phenotypic difference when compared to LEW macrophages, which form very few MGCs at day 6 of cell differentiation (original bars, 50 μm).\
(B) eQTL analysis of the backcross (BC) BMDMs identifies a unique master regulatory locus on rat chromosome 9q11. Genome-wide distribution of *trans*-eQTLs shows a single locus regulating the expression of 190 transcripts in *trans*, suggesting master regulation of the *trans*-eQTL cluster. The detailed eQTL hot spots with the corresponding SNP positions are reported in [Table 1](#tbl1){ref-type="table"}.\
(C) Gene coexpression network of the 190 *trans*-eQTLs is enriched for osteoclast-expressed genes where the master regulatory locus is highlighted in red. Each gene in the network is represented as a circle (node), and the fold change in expression refers to overexpression (blue) or underexpression (green) in osteoclasts as compared to average expression in other cell types ([Supplemental Experimental Procedures](#app3){ref-type="sec"}). Known multinucleation genes (*Mmp9*, *Ctsk*, *P2rx7*, etc.) are indicated with thick circles. The edges represent coexpression between the two transcripts as identified by ARACNE ([@bib42]).\
(D) Genetic linkage showing the principal component of all the *trans*-cluster transcripts (LOD \> 10) together with *trans* eQTLs with variation in gene expression explained by the SNP (*R*^2^) \>0.2. The 2-LOD drop interval (in red) and the underlying positional candidates within 2 Mb are also shown. The annotated gene names are according to RefSeq.\
(E) The *cis*-eQTLs within the 2-LOD drop interval (in red) are shown together with the *trans* cluster. *Treml1*, *Trem2*, *D3ZDX3_Rat*, *Treml2* are positional candidates (*R*^2^ \> 0.25) and among the *trans*-eQTLs, *Kcnn4* (in blue) is the most significant *trans*-eQTL.\
(F) Quantitative real-time PCR analysis on the positional candidates in BC BMDMs according to their genotype (WKY homozygous, WW; WKY/LEW heterozygous, WL). Note that the expression levels of *Trem2* are increased at least 90-fold when compared to other positional candidates.\
Error bars indicate SEM, ^∗^p \< 0.01. See also [Figures S1](#app3){ref-type="sec"} and [S2](#app3){ref-type="sec"}.](gr1){#fig1}

![*Trem2* Is a Master Genetic Regulator of Macrophage Multinucleation Network\
(A) Heatmap of the correlations between macrophage mRNA levels of positional candidates (rows) and all *trans*-regulated genes of MMnet, showing that *Trem2* was positively correlated with the majority (66%) of MMnet transcripts. Red indicates positive correlation and blue indicates negative correlations.\
(B) Heatmap of the correlations between macrophage mRNA levels of positional candidates (rows) and ten *trans*-regulated genes representative of the larger MMnet selected for the siRNA knockdown experiments in rat BMDMs. Red indicates positive correlation and blue indicates negative correlations.\
(C) siRNA against *Trem2*, *Treml2*, *Treml1*, *D3ZDX3*\_*Rat* in rat macrophages followed by measurement of 10 transcripts belonging to the chromosome 9q11 *trans* cluster by quantitative real-time PCR. *Cd68* and *Cd11b* expression levels were assessed as control transcripts that do not belong to MMnet. Given the correlation patterns shown in [Figure 2](#fig2){ref-type="fig"}B, a one-sample t test was used to test for directionality of the effect in the transcriptional response. Knockdown of *Trem2* led to significant (∼50%, p \< 0.001) downregulation of all genes tested, whereas knockdown of *Treml2*, *Treml1*, *D3ZDX3*\_*Rat* did not result in a significant alteration in the expression levels of MMnet genes (p \> 0.1 for all MMnet genes tested). At least n = 3 rats were used in each experiments. Error bars indicate SEM, ^∗^p \< 0.001.\
(D) siRNA-mediated knockdown of TREM2 in human monocyte derived macrophages (MDMs) and the quantitative real-time PCR analysis of ten transcripts from the MMnet. MDMs are from buffy coats from four healthy donors. Error bars indicate SEM, ^∗^p \< 0.05 compared to control (scrambled).\
(E) Knockdown of *TREM2* in human MDMs resulted in transcriptional downregulation of MMnet genes, which significantly correlated with downregulation observed in rat BMDMs (*R*^2^ = 0.69, p = 0.005).](gr2){#fig2}

![*Kcnn4* Regulates Macrophage Multinucleation in Rodents and Humans\
(A) WKY BMDMs were cultured in Lab-Tek chambers and incubated with either scrambled or *Kcnn4* siRNA, and cells were fixed for the assessment of the multinucleation. *Kcnn4* expression levels were measured by quantitative real-time PCR and normalized to *Hprt* expression, showing 80% knockdown in macrophages following incubation with *Kcnn4* siRNA (left panel). Silencing of *Kcnn4* led to a marked reduction in macrophage multinucleation as the number of nuclei in macrophages transfected with Kcnn4 siRNA was significantly reduced (right panel) when compared to controls (mean ± SEM; n = 4 rats). Original bars, 50 μm. p \< 0.001 determined by Kruskal-Wallis test.\
(B) When macrophages were cultured in the presence of TRAM-34 (10 μM), the number of nuclei per 100 macrophages was significantly reduced when compared to cells incubated with the media only (control, basal cells). The results are representative of five independent experiments. Original bars, 50 μm. p \< 0.001 determined by Kruskal-Wallis test.\
(C) BMDMs from 6-week-old *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice were cultured in the presence of macrophage colony stimulating factor (M-CSF) (25 ng/ml) and RANKL (20 ng/ml) for 4 days to induce the differentiation of osteoclasts (upper panel). The formation of osteoclasts measured as the number of TRAP^+^ multinucleated osteoclasts per well increased with time in *Kcnn4*^+/+^ cells but not in *Kcnn4*^−/−^ cells. Mean ± SD; n = 5; the osteoclast number/well was significantly different (p \< 0.001) at all time points; the results are representative of three independent experiments. Original bars, 100 μm.\
(D) Mouse BMDMs were cultured in the presence of M-CSF (25 ng/ml) and RANKL (40 ng/ml) and treated with TRAM-34 or ICA-17043 (both 10 μM, upper panel). TRAM-34 and ICA-17043 treatment on mouse osteoclasts reduced the number of osteoclasts per well in a dose-dependent manner (lower panel, mean ± SD; n = 5). Original bars, 100 μm.\
(E) Human-monocyte-derived macrophages were cultured in Lab-Tek chambers, and spontaneous MGC formation was observed in some buffy coats, and this was significantly reduced when cells were incubated with TRAM-34 (10 μM). At least three separate buffy coats were used to differentiate human macrophages. Original bars, 50 μm. p \< 0.001 determined by Kruskal-Wallis test.\
(F) Human peripheral blood monocytes were cultured in the presence of M-CSF (20 ng/ml) and RANKL (10 ng/ml) for 5 days to induce the differentiation of osteoclasts. Cells were treated with TRAM-34 or ICA-17043 (both 10 μM, left panel). Quantification of osteoclast number per well shows that TRAM-34 and ICA-17043 inhibited the formation of monocyte-derived human osteoclasts in a dose-dependent manner (mean ± SD; n = 4). Original bars, 100 μm.\
See also [Figure S3](#app3){ref-type="sec"}.](gr3){#fig3}

![*Kcnn4* Modulates Bone Homeostasis via Osteoclasts\
(A) Genetic deletion of *Kcnn4* increases bone mass as shown by X-ray analysis performed on femurs from 8-week-old *Kcnn4*^+/+^ and *Kcnn4*^−/−^ female and male mice. Note the stronger radio-opacity in femurs from *Kcnn4*^−/−^ mice when compared with *Kcnn4*^+/+^ mice.\
(B) Peripheral quantitative computed tomography (pQCT) analysis of femoral bones showing total bone density and trabecular bone density of distal femurs from 8-week-old *Kcnn4*^−/−^ mice compared with *Kcnn4*^+/+^ mice (mean ± SD; n = 7--9).\
(C) Representative images of microcomputed tomography (microCT) analysis of distal femurs (left panel) from 8-week-old female and male *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice. Trabecular bone volume fraction from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ female and male mice is shown in the right panel (mean ± SD; n = 7--9).\
(D) Histomorphometry analysis of tibiae from 8-week-old *Kcnn4*^+/+^ and *Kcnn4*^−/−^ female and male mice showing the number of osteoclasts per trabecular bone perimeter (mean ± SD; n = 10).\
(E) Microcomputed tomography analysis of calvaria from 8-week-old *Kcnn4*^−/−^ and *Kcnn4*^+/+^ male and female mice that had received a 2 μl of injection of 25 μg LPS on the right calvaria. Mice were sacrificed 5 days later. Note the low abundance of resorption lacunae in *Kcnn4*^−/−^ mice when compared with wild-type. Calvarial bone volume fraction, bone thickness and bone density were higher, whereas bone surface density was lower in *Kcnn4*^−/−^ mice when compared with wild-type (right panel; mean ± SD; n = 5).\
See also [Figure S4](#app3){ref-type="sec"} and [Table S1](#app3){ref-type="sec"}.](gr4){#fig4}

![Reduced Severity of Glomerulonephritis and Arthritis by Kcnn4 Inactivation\
(A) Glomerular immunohistochemistry showing the effect of specific Kcnn4 blocker TRAM-34 in renal injury in the WKY nephrotoxic nephritis model. Following nephrotoxic serum injection, glomerular crescents (PAS) and percentage of ED1+ macrophages were assessed in control (vehicle) and TRAM-34-treated rats (n = 4 rats were used per group of treatment). Original bars, 20 μm.\
(B) Quantification of glomerular crescents, proteinuria, percentage of ED1^+^ cells and number of glomerular MGCs.\
(C) Collagen antibody-induced arthritis (CAIA) was induced in 2-month-old male and female *Kcnn4*^−/−^ and *Kcnn4*^+/+^ mice (mean ± SD; n = 12--15). Arthritic severity was monitored daily using a visual scoring system as detailed in [Supplemental Experimental Procedures](#app3){ref-type="sec"}. Based on inflammation scoring, *Kcnn4* deletion reduced inflammation in males and females, though the prevention was more efficient in female mice. From day 8 onward, the CAIA mean score is significantly different between *Kcnn4*^+/+^ and *Kcnn4*^−/−^ animals for both genders (p \< 0.001).\
(D) Histopathomorphometry analysis of the paws and the ankles of *Kcnn4*^+/+^ and *Kcnn4*^−/−^ naive and CAIA-induced female mice. All the histomorphometric parameters (inflammation, pannus, cartilage damage, and bone damage) were compared to CAIA *Kcnn4*^+/+^ mice and are significant (mean ± SEM; n = 10--12 mice in each group; p \< 0.05). Similar results were obtained in male mice (data not shown).\
See also [Figure S5](#app3){ref-type="sec"}.](gr5){#fig5}

![Kcnn4 Regulates Ca^2+^-NFATc1 Signaling in Multinucleate Macrophages\
(A) Ca^2+^ oscillations were recorded by intracellular Ca^2+^ imaging using fura-2 in multinucleate osteoclasts from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice. Fluorescence images of cells is shown on the left panel, whereas traces of change in fura-2 fluorescence ratio in single cells treated with M-CSF only or M-CSF and RANKL for 72 hr are shown on the right panel. Note the decrease in Ca^2+^ oscillations associated with *Kcnn4* deficiency, and the absence of Ca^2+^ oscillations in the presence of M-CSF alone, independent of *Kcnn4*. These experiments were repeated multiple times with similar results, and one representative result is shown. Original bars, 50 μm.\
(B) Representative current responses to increasing voltage steps (−100 mV to +80 mV; 400 ms) observed in mouse BMDMs from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice treated with M-CSF (25 ng/ml) and RANKL (40 ng/ml) for 5 days (left panel). I--V plot demonstrates the average current/voltage relationship observed (right panel). Data points for *Kcnn4*^−/−^ and *Kcnn4*^+/+^ macrophages treated with the Kcnn4 inhibitor ICA-17043 (1 μM) were statistically different from *Kcnn4*^+/+^ in the range of −20 mV to +80 mV (mean ± SD, ^∗^p \< 0.05; n = 10), with the exception of *Kcnn4*^+/+^ + ICA-17043 at + 60 mV (mean ± SD, p = 0.06; n = 10) and +80 (mean ± SD, p = 0.11; n = 10). There was no significant difference between *Kcnn4*^−/−^ macrophages and *Kcnn4*^+/+^ treated with ICA-17043.\
(C) NFATc1 protein levels in BMDMs from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice. BMDMs isolated from *Kcnn4*^+/+^ and *Kcnn4*^−/−^ mice were cultured in the presence of M-CSF (25 ng/ml) and RANKL (40 ng/ml) and subjected to western blot analysis at the indicated times using antibodies directed against NFATc1. GAPDH served as an internal control for equal loading of proteins on a SDS-PAGE protein gel. Note the lower abundance of NFATc1 in *Kcnn4*^−/−^ macrophages compared with *Kcnn4*^+/+^ cells. This figure is representative of several experiments performed with similar results.\
(D) BMDMs isolated from *Kcnn4*^−/−^ and *Kcnn4*^+/+^ mice were treated with M-CSF (25 ng/ml) alone or supplemented with RANKL (40 ng/ml) for 5 days and subjected to immunocytochemistry using anti-NFATc1 antibody. Note the decrease in immunoreactive NFATc1 in the nuclei of *Kcnn4*^−/−^ macrophages treated with RANKL compared with *Kcnn4*^+/+^ cells.\
Original bars, 100 μm. See also [Figure S6](#app3){ref-type="sec"}.](gr6){#fig6}

###### 

eQTL Hot Spots Identified in Backcross BMDMs Derived from WKY and LEW

  SNP                                                Chr.   Position (Mb)   Transcripts Mapping to Each SNP   Five Most Strongly Regulated Genes
  -------------------------------------------------- ------ --------------- --------------------------------- ----------------------------------------------------------
  Rn34_1071564105                                    1      71564105        7                                 *RGD1562091 / Zfp61 / Vasp / F1LU75_RAT / Slc26a11*
  Rn34_1071580649                                    1      71580649        6                                 *Gemin7l1 / TMED5_RAT / LOC691921 / Kcnn4 / Trove2*
  Rn34_1084462932                                    1      84462932        7                                 *F1M372_RAT / D3ZBY1_RAT / Flna / Plek / Fn1*
  Rn34_1253288627                                    1      253288627       6                                 *Blnk / LOC689756 / Oasl / Apoc1 / Egr3*
  Rn34_2146742392                                    2      146742392       6                                 *RGD1359508 / Dtwd2 / Hrh1 / RGD1561662 / Lce1l*
  Rn34_2164452465                                    2      164452465       6                                 *Sucnr1 / Tuft1 / Mgrn1 / Dlgap4 / Ptch1*
  Rn34_9003266206                                    9      3266206         29                                *Phlda1 / Pak6 / Xylt1 / Slc30a1 / RGD1565705*
  Rn34_9003796216                                    9      3796216         9                                 *RGD1566226 / D4AE99_RAT / Slc35e4 / RGD1311946 / Hprt1*
  Rn34_9004824426                                    9      4824426         15                                *Plk3 / Capn5 / Bag3 / F1LTZ3_RAT / Ccl22*
  Rn34_9005917596                                    9      5917596         7                                 *Tgfb2 / Leprot / RGD1310371 / Creb3l2 / RTN1_RAT*
  Rn34_9006863573[a](#tblfn1){ref-type="table-fn"}   9      6863573         40                                *Tspan7 / Rdh10 / F1LRS4_RAT / Plcd1 / D3ZC56_RAT*
  Rn34_9007659609[a](#tblfn1){ref-type="table-fn"}   9      7659609         53                                *D3ZC56_RAT / D3ZC56_RAT / Ms4a6b / Myo1d / Bend6*
  Rn34_9008096016[a](#tblfn1){ref-type="table-fn"}   9      8096016         97                                *Kcnn4 / Slco4a1 / Flna / Bcat1 / Atp1a3*
  Rn34_9010210028                                    9      10210028        6                                 *D4ACH5_RAT / St6gal1 / Myh9 / Plek / E9PU51_RAT*

n = 200. eQTL hot spots were defined as significant overrepresentation of *trans*-eQTLs (i.e., any SNP is associated with more than five transcripts; see [Experimental Procedures](#sec4){ref-type="sec"}).

SNPs delineate a genomic region of 1.2 Mb linked to the expression of 190 transcripts, which were located elsewhere in the genome and regulated in *trans* (i.e., *trans*-eQTLs).

[^1]: Co-first author
